TY - JOUR
T1 - Prevalence and characteristics of the Brugada electrocardiogram pattern in patients with arrhythmogenic right ventricular cardiomyopathy
AU - Ueda, Nobuhiko
AU - Nagase, Satoshi
AU - Kataoka, Naoya
AU - Nakajima, Kenzaburo
AU - Kamakura, Tsukasa
AU - Wada, Mitsuru
AU - Yamagata, Kenichiro
AU - Ishibashi, Kohei
AU - Inoue, Yuko
AU - Miyamoto, Koji
AU - Noda, Takashi
AU - Aiba, Takeshi
AU - Izumi, Chisato
AU - Noguchi, Teruo
AU - Ohno, Seiko
AU - Kusano, Kengo
N1 - Funding Information:
This study was supported by the intramural research fund (25‐4‐7, Kengo Kusano) for cardiovascular diseases from the National Cerebral and Cardiovascular Center and JSPS KAKENHI grant number 19K08572, Tokyo, Japan.
Publisher Copyright:
© 2021 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society
PY - 2021/10
Y1 - 2021/10
N2 - Background: Despite distinct pathophysiology, arrhythmogenic right ventricular cardiomyopathy (ARVC) and Brugada syndrome (BrS) exhibit overlapping phenotypes. We investigated the prevalence and characteristics of the Brugada electrocardiogram (ECG) pattern in ARVC patients. Methods: A total of 114 ARVC patients fulfilling the revised Task Force Criteria were enrolled. The Brugada ECG pattern was evaluated according to the consensus report on right precordial leads, and 1141 ECGs (median, 1; interquartile range, 1-16 ECGs/patient) were analyzed. Results: Five patients (4%) showed a Brugada ECG pattern, which disappeared in four patients with ECGs recorded more than 2 years afterward. ARVC patients with the Brugada ECG pattern had a longer PQ interval (220 ± 62 ms vs 180 ± 35 ms, P =.02) and longer QRS duration (138 ± 25 ms vs 102 ± 23 ms, P <.001) than patients without the pattern. During follow-up (median, 11.4; interquartile range, 5.5-17.1 years), 19 ARVC patients experienced cardiac death and 29 experienced heart failure (HF) hospitalization. Kaplan-Meier analysis determined that the Brugada ECG pattern increased the risk of cardiac death and HF hospitalization (log-rank; P <.001, P <.001 respectively). The mean J-point and S-wave amplitudes of the Brugada ECG pattern were 0.29 ± 0.05 mV and 0.34 ± 0.21 mV, respectively, which were significantly lower than those of 26 age-matched BrS patients with a previous ventricular fibrillation episode (0.66 ± 0.33 mV, P <.001 and 0.67 ± 0.39 mV, P =.02 respectively). Conclusion: The Brugada ECG pattern was infrequently encountered, was transient in ARVC patients, and was associated with a longer PQ interval, longer QRS duration, and cardiac events.
AB - Background: Despite distinct pathophysiology, arrhythmogenic right ventricular cardiomyopathy (ARVC) and Brugada syndrome (BrS) exhibit overlapping phenotypes. We investigated the prevalence and characteristics of the Brugada electrocardiogram (ECG) pattern in ARVC patients. Methods: A total of 114 ARVC patients fulfilling the revised Task Force Criteria were enrolled. The Brugada ECG pattern was evaluated according to the consensus report on right precordial leads, and 1141 ECGs (median, 1; interquartile range, 1-16 ECGs/patient) were analyzed. Results: Five patients (4%) showed a Brugada ECG pattern, which disappeared in four patients with ECGs recorded more than 2 years afterward. ARVC patients with the Brugada ECG pattern had a longer PQ interval (220 ± 62 ms vs 180 ± 35 ms, P =.02) and longer QRS duration (138 ± 25 ms vs 102 ± 23 ms, P <.001) than patients without the pattern. During follow-up (median, 11.4; interquartile range, 5.5-17.1 years), 19 ARVC patients experienced cardiac death and 29 experienced heart failure (HF) hospitalization. Kaplan-Meier analysis determined that the Brugada ECG pattern increased the risk of cardiac death and HF hospitalization (log-rank; P <.001, P <.001 respectively). The mean J-point and S-wave amplitudes of the Brugada ECG pattern were 0.29 ± 0.05 mV and 0.34 ± 0.21 mV, respectively, which were significantly lower than those of 26 age-matched BrS patients with a previous ventricular fibrillation episode (0.66 ± 0.33 mV, P <.001 and 0.67 ± 0.39 mV, P =.02 respectively). Conclusion: The Brugada ECG pattern was infrequently encountered, was transient in ARVC patients, and was associated with a longer PQ interval, longer QRS duration, and cardiac events.
KW - Brugada syndrome
KW - arrhythmogenic right ventricular cardiomyopathy
KW - cardiac death
KW - depolarization abnormality
KW - heart failure
UR - http://www.scopus.com/inward/record.url?scp=85113794507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113794507&partnerID=8YFLogxK
U2 - 10.1002/joa3.12628
DO - 10.1002/joa3.12628
M3 - Article
AN - SCOPUS:85113794507
SN - 1880-4276
VL - 37
SP - 1173
EP - 1183
JO - Journal of Arrhythmia
JF - Journal of Arrhythmia
IS - 5
ER -